$OMDA

Omada Health, Inc. (OMDA): Submission of Matters to a Vote of Security Holders

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. omda-20260616 0001611115 false 0001611115 2026-06-16 2026-06-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2026 Date of Report (date of earliest ev

Original reporting
Published Jun 16, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure confirms director elections and ratification of the independent registered public accounting firm for fiscal year 2026; it does not include financial results, guidance, or material corporate actions.

02

Market read

Primarily governance confirmation; not a catalyst for earnings, guidance, or risk repricing.

03

What to watch

Traders may still monitor for follow-on disclosures (e.g., subsequent 10-Q/10-K, compensation updates, or any proxy-related controversies), but none are included here.

Relevance 6/10Novelty 2/10Timing: Filed June 16, 2026 (post-market/filing-day disclosure)

Background

This is an SEC Form 8-K (Item 5.07) reporting final voting results from Omada Health’s 2026 Annual Meeting of Stockholders.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health filed an 8-K confirming stockholder votes to elect Sean Duffy and Trevor Fetter as Class I directors and ratify Deloitte as auditor.

Expected impact

Low likelihood of a sustained price move; any reaction should be limited to event-day noise.

Evidence & confidence

The filing reports governance vote tallies (director election and auditor ratification) without new business, financial, or regulatory developments.

Market effects

Minimal; auditor ratification and director elections do not change sector fundamentals.

Minimal; no regional macro or policy linkage.

Minimal; no international transaction or regulatory action described.

Counterpoint

If investors were concerned about board continuity or auditor changes, the vote outcome could reduce uncertainty, but the filing provides no evidence of a contested or adverse outcome.

Key entities

  • Omada Health, Inc.

    Nasdaq-listed company reporting annual meeting voting results on Form 8-K.

  • Sean Duffy

    Elected as Class I director based on the reported vote totals.

  • Trevor Fetter

    Elected as Class I director based on the reported vote totals.

  • Deloitte & Touche LLP

    Ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch

$7203.TMed

Chinese auto show debuts in Argentina as sales surge

Argentina hosts its first Chinese auto show as Chinese brands gain market share, accounting for 10% of August sales. BYD 002594.SZ is now the ninth best-selling brand. Over 20 Chinese brands, including Geely 0175.HK and Chery 9973.HK, were displayed. Toyota 7203.T plans a $1.34B EV plant. Tesla may enter Argentina. Car sales fell 13% YoY due to market adjustment and high interest rates.